The age-old question of which came first “the chicken or the egg” takes on new meaning this week in relation to what you can eat and, more importantly, in what order. Dr. Alpana Shukla, Assistant Professor, Weill Cornell Medicine, sat down with Joy Pape, our Medical Editor, at the recent ADA …
Read More »Daily Archives: Sep 11, 2018
When Starting a GLP-1 for Weight Loss
Although GLP-1's don't usually cause hypoglycemia except when given with insulin or a sulfonylurea, I have found that when patients who do not have diabetes are started on a GLP-1, some can have symptoms of hypoglycemia and/or more untoward GI side effects if they start when they come in the office fasting.
Read More »Alpana Shukla Complete Interview
Alpana Shukla MD, MRCP (UK) graduated from Grant Medical College Mumbai, India and trained in Endocrinology in the UK and Australia. She is Assistant Professor of Research in the Division of Endocrinology, Diabetes & Metabolism at Weill Cornell Medical College, and Director of Clinical Research at the Comprehensive Weight Control Center. Dr Shukla is a research mentor for the MS program at the Institute of Human Nutrition, Columbia University. Her research interests and publications include novel behavioral interventions for management of type 2 diabetes and obesity, pharmacotherapy for obesity, and metabolic surgery.
Read More »Eversense CGM System Part 4
In the conclusion of this week's Homerun Slides, the clinical performance of the Eversense CGM System.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #142: The Genetics of Type 2 Diabetes Part 4
High density mapping: GWAS do not inevitably lead to identification of a gene or genes in a given locus associated with disease.The most strongly associated SNPs are often only markers for the functional variant responsible for the observed genetic effect and most associated regions harbor several genes. Therefore, additional fine mapping of the loci in even larger sample sets is often necessary. To do this cost-efficiently a Cardio-Metabochip has been developed for metabolic/cardiovascular gene mapping. This custom-design Illumina Infinium genotyping chip contains ∼200,000 polymorphisms selected to cover association signals from a wide range of metabolic disorders (T2DM, lipid disorders, obesity, and cardiovascular disease), was designed to perform both deep replication of major disease signals and fine mapping of established loci. Meta-analysis of previous GWAS with an additional 22,669 T2DM cases and 58,119 controls genotyped using the Cardio-Metabochip has recently added another eight new loci associated with T2DM in the European population
Read More »Alpana Shukla 2018 Transcript
In this Exclusive Interview transcript, Dr. Alpana Shukla talks about Food Order studies and the dramatic impact eating carbs last during meals can have on blood glucose levels and other indicators.
Read More »Alpana Shukla 2018 Full Interview
In this Exclusive Interview, Alpana Shukla talks with Diabetes in Control Medical Editor Joy Pape during the ADA 2018 convention in Orlando about the Food Order Study.
Read More »Alpana Shukla Part 1, Food Order Studies
In part 1 of this Exclusive Interview, Alpana Shukla talks with Diabetes in Control Medical Editor Joy Pape about the purpose and findings in the Food Order Studies.
Read More »Alpana Shukla Part 2, Food Order VS Protein Preload
In part 2 of this Exclusive Interview, Alpana Shukla talks with Diabetes in Control Medical Editor Joy Pape about the differences between the real-world food order study and protein preloading.
Read More »Alpana Shukla Part 3, On What Type of Diabetes Does Food Order Work Best
In part 3 of this Exclusive Interview, Alpana Shukla talks with Diabetes in Control Medical Editor Joy Pape about the relevance of the study for people with any type of diabetes or no diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.